Healios KK Ord Shs HLOSF

Healthcare Biotechnology

HEALIOS K.K. is a Japan-based company mainly engaged in research and development of pharmaceutical products. The Company has compound pharmaceutical products line and induced pluripotent stem cell (iPSC) regenerative medicine product line. The compound pharmaceutical product line contains HLM0021, HLM0022 and HLM0023. The products are ophthalmological surgery adjuvants, mainly contain brilliant blue G-250 (BBG250) which help capsule temporarily safely stained to protect the inner limiting membranes and lens during surgery of vitreous and cataract. The iPSC regenerative medicine product line contains HLCR011 and HLCR012. The products are in the preclinical testing and preparation for trial in Japan, which are candidate of regenerative medicine products. The products are iPS cell derived retinal pigment epithelium (RPE) cell suspension and sheet developed in Japan, United States and Europe.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by The300on Oct 17, 2011 7:57pm

226 Views

Post# 19157434

Depth and Thoughts

It looks like whoever had their foot on Halo's throat has decided to let it breathe a little.

Bids have been building and asks are being pulled.

Its either your classic case of manipulation (both up and down) or news is coming down the pipe and as always the inner circle is privy and accumulating. Either way, its nice to see some green instead of the perma-red we've been seeing these past few months.

I wouldn't be surprised to see news of Hudbay making an offer for either the entire company or parts of it at these bargin basement prices.

# Orders	Shares	Bid	Ask	Shares	# Orders
2	30000	0.130	0.145	23000	2
2	50500	0.125	0.180	34000	2
2	9000	0.120	0.195	3000	1
2	13000	0.115	0.210	1000	1
2	18000	0.110	0.250	5000	1